These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15315473)

  • 1. Common pathways of depression and pain.
    Delgado PL
    J Clin Psychiatry; 2004; 65 Suppl 12():16-9. PubMed ID: 15315473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical symptoms comorbid with depression and the new antidepressant duloxetine.
    Bailey KP
    J Psychosoc Nurs Ment Health Serv; 2003 Dec; 41(12):13-8. PubMed ID: 14682027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Depression and pain: novel clinical, neurobiological and psychopharmacological data].
    Jaracz J; Rybakowski J
    Psychiatr Pol; 2005; 39(5):937-50. PubMed ID: 16358593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of duloxetine on painful physical symptoms associated with depression.
    Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
    Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the serotonergic and noradrenergic neurotransmitter systems in the treatment of psychological and physical symptoms of depression.
    Fava M
    J Clin Psychiatry; 2003; 64 Suppl 13():26-9. PubMed ID: 14552653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does depression hurt?
    Stahl SM
    J Clin Psychiatry; 2002 Apr; 63(4):273-4. PubMed ID: 12000200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is there a place for duloxetine?
    Drug Ther Bull; 2007 Apr; 45(4):29-32. PubMed ID: 17451072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical symptoms of depression: unmet needs in special populations.
    Stewart DE
    J Clin Psychiatry; 2003; 64 Suppl 7():12-6. PubMed ID: 12755647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants.
    Stahl SM; Grady MM; Moret C; Briley M
    CNS Spectr; 2005 Sep; 10(9):732-47. PubMed ID: 16142213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic benefits of serotonin and noradrenaline reuptake inhibition.
    Nelson JC
    Depress Anxiety; 1998; 7 Suppl 1():5-6. PubMed ID: 9597344
    [No Abstract]   [Full Text] [Related]  

  • 12. Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.
    Westanmo AD; Gayken J; Haight R
    Am J Health Syst Pharm; 2005 Dec; 62(23):2481-90. PubMed ID: 16303903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
    Lee SI; Keltner NL
    Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
    [No Abstract]   [Full Text] [Related]  

  • 14. Antidepressant options: venlafaxine in perspective.
    Thase ME
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):10S-18S; discussion 18S-20S. PubMed ID: 8784644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
    Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
    Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
    Schatzberg AF
    J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
    Andrews JM; Ninan PT; Nemeroff CB
    Depression; 1996; 4(2):48-56. PubMed ID: 9160640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of venlafaxine and duloxetine in the treatment of depression with decremental changes in somatic symptoms of pain, chronic pain, and the pharmacokinetics and clinical considerations of duloxetine pharmacotherapy.
    Barkin RL; Barkin S
    Am J Ther; 2005; 12(5):431-8. PubMed ID: 16148429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dual acting reuptake inhibitors in the treatment of depression and pain].
    Hajak G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S280-3. PubMed ID: 17139587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNRIs in the management of acute major depressive disorder.
    Zajecka JM; Albano D
    J Clin Psychiatry; 2004; 65 Suppl 17():11-8. PubMed ID: 15600377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.